Results 101 to 110 of about 11,453 (268)

Combined anatomical and clinical factors for the long-term risk stratification of patients undergoing percutaneous coronary intervention: the Logistic Clinical SYNTAX score [PDF]

, 2017
Background The SYNTAX score (SXscore), an anatomical-based scoring tool reflecting the complexity of coronary anatomy, has established itself as an important long-term prognostic factor in patients undergoing percutaneous coronary intervention (PCI). The
Dawkins, Keith D., de Vries, Ton, Diletti, Roberto, Farooq, Vasim, Garcia-Garcia, Hector, Kappetein, Arie Pieter, Morel, Marie Angèle, Räber, Lorenz, Serruys, Patrick W., Steyerberg, Ewout W., Swart, Michael, Valgimigli, Marco, Vergouwe, Yvonne, Vranckx, Pascal, Windecker, Stephan   +14 more
core  

Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina [PDF]

, 2002
BACKGROUND: Earlier reports have shown that the outcome of balloon angioplasty or bypass surgery in unstable angina is less favorable than in stable angina.
Beyar, R., Cauwelaert, C. van, Crean, P.A. (Peter), Feyter, P.J. (Pim) de, Heuvel, P. van den, Lindeboom, W.K. (Wietze), McGovern, E., Milo, S., Penn, I.M. (Ian), Regensburger, D., Serruys, P.W.J.C. (Patrick), Simon, R. (Rudiger), Tyers, G.F.O. (Frank), Unger, F. (Felix), Valk, V. (Vincent) de   +14 more
core   +2 more sources

Tirofiban in emergency conditions

The American Journal of Emergency Medicine, 2022
Aleksandra Gasecka, Krzysztof J. Filipiak, Miłosz Jaguszewski, Lukasz Szarpak, Zubaid Rafique   +4 more
openaire   +2 more sources

The safety and efficacy of intra-arterial low-dose tirofiban administration during endovascular therapy in patients with large ischemic core volume

Scientific Reports
This study aimed to evaluate the safety and efficacy of intra-arterial (IA) administration of low- dose tirofiban during endovascular therapy in patients with large ischemic core volumes on initial brain CT. Patients were divided into two groups based on
Kwang-Chun Cho, Nak-Hoon Son, So Hyeon Gwon, Jin Wook Choi, Woo Sang Jung   +4 more
doaj   +1 more source

Cost-effectiveness of tirofiban for acute ischemic stroke without large or medium-sized vessel occlusion: A Markov modelling analysis from the Chinese and United States perspectives.

PLoS ONE
BackgroundThe RESCUE BT2 trial recently showcased the efficacy of tirofiban in treating acute ischemic stroke (AIS) without large or medium-sized vessel occlusion.
Li Wang, Yuhong Zeng, Limei Zhou, Ping Xu, Xianbin Guo, Yu Xie, Junxiu Cai, Min Pan, Jie Tang, Qingtao Gong, Rong Su, Yan Liu, Yake Lou   +12 more
doaj   +1 more source

Platelet Inhibition in Percutaneous Coronary Interventions [PDF]

, 2018
: Mechanical disruption of atherosclerotic plaques at the time of percutaneous coronary intervention (PCI) is a potent stimulus for arterial thrombosis.
Roffi, Marco, Wyss, Christophe
core  

Elucidating the role of Staphylococcus epidermidis serine-aspartate repeat protein G in platelet activation. [PDF]

, 2009
BACKGROUND: Staphylococcus epidermidis is a commensal of the human skin that has been implicated in infective endocarditis and infections involving implanted medical devices. S. epidermidis induces platelet aggregation by an unknown mechanism.
Arasu, S, Brennan, Marian P, Chubb, Anthony J, Cox, Dermot, Devocelle, Marc, Foster, T J, Loughman, A   +6 more
core   +2 more sources

Molecular basis for Staphylococcus aureus-mediated platelet aggregate formation under arterial shear in vitro. [PDF]

, 2008
OBJECTIVE: Staphylococcus aureus is the most frequent causative organism of infective endocarditis (IE) and is characterized by thrombus formation on a cardiac valve that can embolize to a distant site. Previously, we showed that S.
Clarke, Niamh, Cox, Dermot, Foster, Timothy J, Kerrigan, Steven W, Loughman, Anthony, Meade, Gerardene   +5 more
core  

Novel strategies for assessing platelet reactivity [PDF]

, 2016
There are many approaches to assessing platelet reactivity and many uses for such measurements. Initially, measurements were based on the ability of platelets separated from other blood cells to aggregate together following activation with an appropriate
Dovlatova N, Heptinstall S, Heptinstall S, Holm M, Johnson A, Kaplan ZS, Laohathai P, Mohammad Algahtani, Papapanagiotou A, Stan Heptinstall, Zhao L   +10 more
core   +2 more sources

Tirofiban (Aggrastat®) [PDF]

Cardiovascular Drug Reviews, 1999
Frederick L. Sax and, Eliav Barr, Bohumil Bednar, Mark E. Duggan, Melissa S. Egbertson, Man-Wai Lo, Gail Murphy, Joseph J. Lynch, Jacquelynn J. Cook, Wasyl Halczenko, George D. Hartman, Lawrence I. Deckelbaum, Robert J. Gould   +12 more
openaire   +2 more sources